Semaglutide Wellness Tips for Chronic Kidney Disease and Obesity - Health

survey show positive effects of Semaglutide on chronic kidney disease and Obesity

A Holocene International survey light-emitting_diode by clinical pharmacologist Hiddo L. Heerspink from the University Medical Center Groningen in the Netherlands uncover that the diabetes medicine semaglutide, also know as Ozempic, has show positive result for patient with Chronic kidney disease and fleshiness. The survey, print in Nature Medicine and show at the annual Congress of the American Society of Nephrology, show that semaglutide reduce the sum of protein in the urine, decrease kidney inflammation, and lower blood pressure for participants.

In the survey, conduct across four state, one-half of the 101 participant receive 24-week injection of semaglutide, while the other one-half receive a placebo. consequence show a significant decrease of 52% in the sum of protein in the urine, along with a 30% decrease in kidney inflammation. Additionally, participant experience a drop in blood pressure comparable to that of a blood pressure-lowering drug, and a 33% decrease in a key measure of heart failure. Furthermore, participant doomed approximately 10% of their weight during the study.

 Heerspink express enthusiasm about the consequence, highlight the direct and indirect impact of the drug on the kidney. Semaglutide not only directly affect inflammation parameter and fat tissue around the kidney but also indirectly reduce participant' weight and blood pressure.

The survey, however, was too short to measure improvement in the quality of life for participant or buttocks medium-term effects.

Semaglutide Wellness Tips for Chronic Kidney Disease and Obesity

look ahead, Heerspink is optimistic about conducting bigger survey to research whether semaglutide could lead to fewer dialysis or kidney graft. However, challenge exist in obtain sufficient measure of the drug for foster survey due to its high demand.

impact of Semaglutide on type 2 diabetes and Obesity

Semaglutide, a GLP-1 receptor protagonist, has been primarily plan to dainty Type 2 diabetes. The drug affect the intestinal hormone GLP-1, which play a crucial function in carbohydrate processing by stimulate insulin release and reduction hunger. Additionally, GLP-1 decelerate down the motion of food from the stomach to the intestine, supply a prolong feeling of comprehensiveness that AIDS in weight loss. These effects lend to better glucose control and weight management for individuals.

The class of drug semaglutide belong to has show promise consequence in address assorted health conditions, include chronic kidney disease and fleshiness. travel forward, foster research and clinical test are necessitate to research the full_moon potential of semaglutide in treat a scope of health issue beyond its primary indication for type 2 diabetes.